Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31051938 | 0.89 | ADRB1 (0.34) | ADRB1ALDH1A1LMNAHTR2AHTR2C | |
| SCHEMBL31052247 | 0.79 | ADRB1 (0.55) | ADRB1ALDH1A1LMNAHTR2AHTR2C | |
| SCHEMBL31051885 | 0.77 | DRD2 (0.47) | ADRB1HTR2ADRD2DRD1DRD3 | |
| SCHEMBL31052040 | 0.77 | DRD2 (0.43) | ADRB1HTR2ADRD2DRD1DRD3 | |
| SCHEMBL31052190 | 0.77 | ADRB1 (0.61) | ADRB1ALDH1A1LMNAHTR2ADRD2 | |
| SCHEMBL31052101 | 0.73 | HTR6 (0.38) | ADRB1HTR2ADRD2DRD1DRD3 | |
| SCHEMBL31052211 | 0.73 | ADRB1 (0.37) | ADRB1ALDH1A1LMNAHTR2AHTR2C | |
| SCHEMBL31052018 | 0.70 | HTR2C (0.42) | ADRB1HTR2AHTR2CHTR2BDRD2 | |
| SCHEMBL31051787 | 0.70 | ADRB1 (0.38) | ADRB1HTR2AHTR2CHTR2B | |
| SCHEMBL31051969 | 0.70 | DRD2 (0.43) | ADRB1HTR2AHTR2CHTR2BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678188-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR MANAGING BILIRUBIN-INDUCED NEUROLOGICAL DYSFUNCTION, PSYCHIATRIC DISORDERS ASSOCIATED WITH JAUNDICE, OR PSYCHIATRIC DISORDERS CAUSED BY BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS | Ohnishi, Arata (JP) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024185842-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING, PREVENTING, OR MANAGING BILIRUBIN-INDUCED NEUROLOGICAL DYSFUNCTION, PSYCHIATRIC DISORDERS ASSOCIATED WITH JAUNDICE, OR PSYCHIATRIC DISORDERS CAUSED BY BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE MUTATIONS | 国立大学法人島根大学 | 2024-09-12 | — | — | WO | disclosed |